These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31419624)

  • 21. Chemical Protein Degradation Approach and its Application to Epigenetic Targets.
    Itoh Y
    Chem Rec; 2018 Dec; 18(12):1681-1700. PubMed ID: 29893461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing Different E3 Ligases for Small Molecule Induced Protein Ubiquitination and Degradation.
    Ottis P; Toure M; Cromm PM; Ko E; Gustafson JL; Crews CM
    ACS Chem Biol; 2017 Oct; 12(10):2570-2578. PubMed ID: 28767222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PROTAC-mediated crosstalk between E3 ligases.
    Steinebach C; Kehm H; Lindner S; Vu LP; Köpff S; López Mármol Á; Weiler C; Wagner KG; Reichenzeller M; Krönke J; Gütschow M
    Chem Commun (Camb); 2019 Feb; 55(12):1821-1824. PubMed ID: 30672516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monovalent protein-degraders - Insights and future perspectives.
    Cornella-Taracido I; Garcia-Echeverria C
    Bioorg Med Chem Lett; 2020 Jun; 30(12):127202. PubMed ID: 32331933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delineating the role of cooperativity in the design of potent PROTACs for BTK.
    Zorba A; Nguyen C; Xu Y; Starr J; Borzilleri K; Smith J; Zhu H; Farley KA; Ding W; Schiemer J; Feng X; Chang JS; Uccello DP; Young JA; Garcia-Irrizary CN; Czabaniuk L; Schuff B; Oliver R; Montgomery J; Hayward MM; Coe J; Chen J; Niosi M; Luthra S; Shah JC; El-Kattan A; Qiu X; West GM; Noe MC; Shanmugasundaram V; Gilbert AM; Brown MF; Calabrese MF
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7285-E7292. PubMed ID: 30012605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein degradation: a validated therapeutic strategy with exciting prospects.
    Lebraud H; Heightman TD
    Essays Biochem; 2017 Nov; 61(5):517-527. PubMed ID: 28970340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photoactive Bifunctional Degraders: Precision Tools To Regulate Protein Stability.
    Kounde CS; Tate EW
    J Med Chem; 2020 Dec; 63(24):15483-15493. PubMed ID: 33226810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted protein degradation by PROTACs.
    Neklesa TK; Winkler JD; Crews CM
    Pharmacol Ther; 2017 Jun; 174():138-144. PubMed ID: 28223226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular chaperones in targeting misfolded proteins for ubiquitin-dependent degradation.
    Kriegenburg F; Ellgaard L; Hartmann-Petersen R
    FEBS J; 2012 Feb; 279(4):532-42. PubMed ID: 22177318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-molecule approaches to characterizing kinetics of biomolecular interactions.
    van Oijen AM
    Curr Opin Biotechnol; 2011 Feb; 22(1):75-80. PubMed ID: 21036593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noncovalent probes for the investigation of structure and dynamics of protein-nucleic acid assemblies: the case of NC-mediated dimerization of genomic RNA in HIV-1.
    Turner KB; Kohlway AS; Hagan NA; Fabris D
    Biopolymers; 2009 Apr; 91(4):283-96. PubMed ID: 18946871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unifying principles of bifunctional, proximity-inducing small molecules.
    Gerry CJ; Schreiber SL
    Nat Chem Biol; 2020 Apr; 16(4):369-378. PubMed ID: 32198490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical control over protein-protein interactions: beyond inhibitors.
    Gestwicki JE; Marinec PS
    Comb Chem High Throughput Screen; 2007 Sep; 10(8):667-75. PubMed ID: 18045079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligomeric Remodeling by Molecular Glues Revealed Using Native Mass Spectrometry and Mass Photometry.
    Huang X; Kamadurai H; Siuti P; Ahmed E; Bennett JL; Donald WA
    J Am Chem Soc; 2023 Jul; 145(27):14716-14726. PubMed ID: 37379266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substrate properties of ubiquitin carboxyl-terminally derived peptide probes for protein ubiquitination.
    Madden MM; Song W; Martell PG; Ren Y; Feng J; Lin Q
    Biochemistry; 2008 Mar; 47(12):3636-44. PubMed ID: 18307316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy.
    Ohoka N; Shibata N; Hattori T; Naito M
    Curr Cancer Drug Targets; 2016; 16(2):136-46. PubMed ID: 26560118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action.
    Riching KM; Mahan S; Corona CR; McDougall M; Vasta JD; Robers MB; Urh M; Daniels DL
    ACS Chem Biol; 2018 Sep; 13(9):2758-2770. PubMed ID: 30137962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
    Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
    Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of E2~ubiquitin conjugates for the characterization of ubiquitin transfer by RING E3 ligases such as the inhibitor of apoptosis proteins.
    Middleton AJ; Budhidarmo R; Day CL
    Methods Enzymol; 2014; 545():243-63. PubMed ID: 25065893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein-protein interfaces in molecular glue-induced ternary complexes: classification, characterization, and prediction.
    Rui H; Ashton KS; Min J; Wang C; Potts PR
    RSC Chem Biol; 2023 Mar; 4(3):192-215. PubMed ID: 36908699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.